Safety and efficacy of strength training in patients with sporadic inclusion body myositis

Muscle and Nerve

Volumn 20, Issue 10, 1997, Pages 1242-1248

  Spector, Sidney A ^a   Lemmer, Jeffery T ^c   Koffman, Boyd M ^a   Fleisher, T A ^b   Feuerstein, Irwin M ^b,d   Hurley, Ben F ^c   Dalakas, Marinos C ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Exercise; Immune function; Inclusion body myositis; Muscle injury

Indexed keywords

CREATINE KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EXERCISE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; INCLUSION BODY MYOSITIS; MALE; MUSCLE INJURY; MUSCLE STRENGTH; MUSCLE TRAINING; PRIORITY JOURNAL;

ACTIVITIES OF DAILY LIVING; AGED; BIOLOGICAL MARKERS; CYTOKINES; ENDOCRINE GLANDS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MUSCLE FATIGUE; MUSCLES; MYOSITIS, INCLUSION BODY; PHYSICAL THERAPY MODALITIES; PILOT PROJECTS; SAFETY; TREATMENT OUTCOME;

EID: 0030855924     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C     Document Type: Article

References (11)

1. Aitkens SG, Megan BA, McCrory MA, Kilmer DD, Bernauer EM: Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 1993;74:711-715.
2. Arahata K, Engel AG: Monoclonal antibody analysis of mono-nuclear cells in myopathies. V. Identification and quantitation of T8+ cytotoxic and T8+ suppresser cells. Ann Neural 1988; 23:493-499.
3. Baker D, Wilson G, Carlyon B: Generality versus specificity: a comparison of dynamic and isometric measures of strength and speed-strength. Eur J Appl Physiol 1994;68:350-355.
4. Bradley WG, Tandan R: Inflammatory diseases of muscle, in Kelley WN, Harris ED, Ruddy S, Sledge CB (eds): Textbook of Rheumatology. Philadelphia, Saunders, 1989, p 1283.
5. Cannon JG, Meydani SN, Fielding RA, Fiatarone MA, Heydani M, Farhangmehr M, Orencloe SF, Blumberg JB, Evans WJ: Acute phase response in exercise. II. Association between vitamin E, cytokines, and muscle proteolysis. Am J Physiol 1991; 260:R1235-R1240.
6. Carpenter S, Karpati G, Heller I, Eisen A: Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 1978;28:8-17.
7. Clarkson PM, Byrnes WC, McCormick KM, Turcotte LP, White JS: Muscle soreness and serum creatine kinase activity following isometric, eccentric and concentric exercise. Int J Sports Med 1986;7:152-155.
8. Dalakas MC: Inflammatory myopathies: pathogenesis and treatment. Neuropharmacology 1992;5:327-351.
9. Dalakas MC: Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325:1487-1498.
10. Escalante A, Miller L, Beardmore TD: Resistive exercise in the rehabilitation of polymyositis/dermatomyositis. J Rheumatol 1993;20:1340-1344.
11. Evans WJ, Campbell WW: Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 1993;123: 465-468.